C/EBPβ (CCAAT/enhancer binding protein) controls cell fate determination during mammary gland development

Tiffany Seagroves, John P. Lydon, Russell C. Hovey, Barbara K. Vonderhaar, Jeffrey M. Rosen

Research output: Contribution to journalArticle

138 Citations (Scopus)

Abstract

Deletion of the transcription factor CCAAT/enhancer binding protein (C/EBP)β results in a severe inhibition of lobuloalveolar development in the mouse mammary gland. Because progesterone receptor (PR) is requisite for alveolar development, the expression of PR was investigated in C/EBPβ-/- mice. Unexpectedly, the number of PR-positive cells, as well as the levels of PR mRNA, were elevated 3-fold in the mammary glands of C/EBPβ-/- mice. Furthermore, in contrast to wild-type nulliparous mice, in which PR distribution shifted from a uniform to nonuniform pattern between 8-12 weeks of age, C/EBPβ-/- mice exhibited uniform PR distribution throughout all stages of mammary development analyzed. No change in C/EBPβ mRNA levels was observed in the mammary glands of PR-/- mice, suggesting that PR acts in a pathway either in parallel to or downstream of C/EBPβ. The overexpression and disrupted cellular distribution of PR in C/EBPβ-/- mice were coincident with a striking 10-fold decrease in cell proliferation after acute steroid hormone treatment, assayed by incorporation of bromodeoxyuridine. In wild-type mice, PR and bromodeoxyuridine-positive cells were adjacent to each other and rarely colocalized. No differences in the level or pattern of PR expression were observed in the uterus, suggesting that C/EBPβ influences PR in a mammary-specific fashion. Together, these data suggest that C/EBPβ may control cell fate decisions in the mammary gland through the appropriate temporal and spatial expression of molecular markers, such as PR, that induce the proliferation of alveolar progenitor cells via juxtacrine mechanisms.

Original languageEnglish (US)
Pages (from-to)359-368
Number of pages10
JournalMolecular Endocrinology
Volume14
Issue number3
DOIs
StatePublished - Dec 1 2000

Fingerprint

CCAAT-Enhancer-Binding Proteins
Progesterone Receptors
Human Mammary Glands
Bromodeoxyuridine
Breast
Alveolar Epithelial Cells
Messenger RNA

All Science Journal Classification (ASJC) codes

  • Molecular Biology
  • Endocrinology

Cite this

C/EBPβ (CCAAT/enhancer binding protein) controls cell fate determination during mammary gland development. / Seagroves, Tiffany; Lydon, John P.; Hovey, Russell C.; Vonderhaar, Barbara K.; Rosen, Jeffrey M.

In: Molecular Endocrinology, Vol. 14, No. 3, 01.12.2000, p. 359-368.

Research output: Contribution to journalArticle

Seagroves, Tiffany ; Lydon, John P. ; Hovey, Russell C. ; Vonderhaar, Barbara K. ; Rosen, Jeffrey M. / C/EBPβ (CCAAT/enhancer binding protein) controls cell fate determination during mammary gland development. In: Molecular Endocrinology. 2000 ; Vol. 14, No. 3. pp. 359-368.
@article{f5afa1153431423198d6957e1bbadffd,
title = "C/EBPβ (CCAAT/enhancer binding protein) controls cell fate determination during mammary gland development",
abstract = "Deletion of the transcription factor CCAAT/enhancer binding protein (C/EBP)β results in a severe inhibition of lobuloalveolar development in the mouse mammary gland. Because progesterone receptor (PR) is requisite for alveolar development, the expression of PR was investigated in C/EBPβ-/- mice. Unexpectedly, the number of PR-positive cells, as well as the levels of PR mRNA, were elevated 3-fold in the mammary glands of C/EBPβ-/- mice. Furthermore, in contrast to wild-type nulliparous mice, in which PR distribution shifted from a uniform to nonuniform pattern between 8-12 weeks of age, C/EBPβ-/- mice exhibited uniform PR distribution throughout all stages of mammary development analyzed. No change in C/EBPβ mRNA levels was observed in the mammary glands of PR-/- mice, suggesting that PR acts in a pathway either in parallel to or downstream of C/EBPβ. The overexpression and disrupted cellular distribution of PR in C/EBPβ-/- mice were coincident with a striking 10-fold decrease in cell proliferation after acute steroid hormone treatment, assayed by incorporation of bromodeoxyuridine. In wild-type mice, PR and bromodeoxyuridine-positive cells were adjacent to each other and rarely colocalized. No differences in the level or pattern of PR expression were observed in the uterus, suggesting that C/EBPβ influences PR in a mammary-specific fashion. Together, these data suggest that C/EBPβ may control cell fate decisions in the mammary gland through the appropriate temporal and spatial expression of molecular markers, such as PR, that induce the proliferation of alveolar progenitor cells via juxtacrine mechanisms.",
author = "Tiffany Seagroves and Lydon, {John P.} and Hovey, {Russell C.} and Vonderhaar, {Barbara K.} and Rosen, {Jeffrey M.}",
year = "2000",
month = "12",
day = "1",
doi = "10.1210/me.14.3.359",
language = "English (US)",
volume = "14",
pages = "359--368",
journal = "Molecular Endocrinology",
issn = "0888-8809",
publisher = "The Endocrine Society",
number = "3",

}

TY - JOUR

T1 - C/EBPβ (CCAAT/enhancer binding protein) controls cell fate determination during mammary gland development

AU - Seagroves, Tiffany

AU - Lydon, John P.

AU - Hovey, Russell C.

AU - Vonderhaar, Barbara K.

AU - Rosen, Jeffrey M.

PY - 2000/12/1

Y1 - 2000/12/1

N2 - Deletion of the transcription factor CCAAT/enhancer binding protein (C/EBP)β results in a severe inhibition of lobuloalveolar development in the mouse mammary gland. Because progesterone receptor (PR) is requisite for alveolar development, the expression of PR was investigated in C/EBPβ-/- mice. Unexpectedly, the number of PR-positive cells, as well as the levels of PR mRNA, were elevated 3-fold in the mammary glands of C/EBPβ-/- mice. Furthermore, in contrast to wild-type nulliparous mice, in which PR distribution shifted from a uniform to nonuniform pattern between 8-12 weeks of age, C/EBPβ-/- mice exhibited uniform PR distribution throughout all stages of mammary development analyzed. No change in C/EBPβ mRNA levels was observed in the mammary glands of PR-/- mice, suggesting that PR acts in a pathway either in parallel to or downstream of C/EBPβ. The overexpression and disrupted cellular distribution of PR in C/EBPβ-/- mice were coincident with a striking 10-fold decrease in cell proliferation after acute steroid hormone treatment, assayed by incorporation of bromodeoxyuridine. In wild-type mice, PR and bromodeoxyuridine-positive cells were adjacent to each other and rarely colocalized. No differences in the level or pattern of PR expression were observed in the uterus, suggesting that C/EBPβ influences PR in a mammary-specific fashion. Together, these data suggest that C/EBPβ may control cell fate decisions in the mammary gland through the appropriate temporal and spatial expression of molecular markers, such as PR, that induce the proliferation of alveolar progenitor cells via juxtacrine mechanisms.

AB - Deletion of the transcription factor CCAAT/enhancer binding protein (C/EBP)β results in a severe inhibition of lobuloalveolar development in the mouse mammary gland. Because progesterone receptor (PR) is requisite for alveolar development, the expression of PR was investigated in C/EBPβ-/- mice. Unexpectedly, the number of PR-positive cells, as well as the levels of PR mRNA, were elevated 3-fold in the mammary glands of C/EBPβ-/- mice. Furthermore, in contrast to wild-type nulliparous mice, in which PR distribution shifted from a uniform to nonuniform pattern between 8-12 weeks of age, C/EBPβ-/- mice exhibited uniform PR distribution throughout all stages of mammary development analyzed. No change in C/EBPβ mRNA levels was observed in the mammary glands of PR-/- mice, suggesting that PR acts in a pathway either in parallel to or downstream of C/EBPβ. The overexpression and disrupted cellular distribution of PR in C/EBPβ-/- mice were coincident with a striking 10-fold decrease in cell proliferation after acute steroid hormone treatment, assayed by incorporation of bromodeoxyuridine. In wild-type mice, PR and bromodeoxyuridine-positive cells were adjacent to each other and rarely colocalized. No differences in the level or pattern of PR expression were observed in the uterus, suggesting that C/EBPβ influences PR in a mammary-specific fashion. Together, these data suggest that C/EBPβ may control cell fate decisions in the mammary gland through the appropriate temporal and spatial expression of molecular markers, such as PR, that induce the proliferation of alveolar progenitor cells via juxtacrine mechanisms.

UR - http://www.scopus.com/inward/record.url?scp=0034335414&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034335414&partnerID=8YFLogxK

U2 - 10.1210/me.14.3.359

DO - 10.1210/me.14.3.359

M3 - Article

VL - 14

SP - 359

EP - 368

JO - Molecular Endocrinology

JF - Molecular Endocrinology

SN - 0888-8809

IS - 3

ER -